DNA MARKER FOR PROGNOSIS PREDICTION FOR FIRST-LINE PLATINUM-BASED CHEMOTHERAPY FOR PATIENTS WITH UNRESECTABLE NON-SMALL CELL LUNG CANCER

摘要

The present invention provides a DNA marker for prognosis prediction for first-line platinum-based chemotherapy for patients with non-small cell lung cancer, comprising rs50872(GA) SNP for an accurate prognosis prediction for first-line platinum-based chemotherapy for patients with non-small cell lung cancer.